Page 50 - NATIONAL INSTITUTES OF HEALTH (NIH) GUIDELINES FOR CONDUCTING RESEARCH IN MINISTRY OF HEALTH (MOH) INSTITUTIONS & FACILITIES 3RD EDITION 2021

18. National Committee for Clinical Research (NCCR) (2018). Term of Reference and Stan-
dard Operating Procedure, Scientific Review Panel for First-in-Human/First Dose in
Human Trials in Malaysia, Version 1.5, October 2018.
19. Jabatan Kemajuan Orang Asli (2020). Prosedur Bagi Permohonan Penyelidikan Di Per-
kampungan Orang Asli Atau Fasiliti Jabatan Kemajuan Orang Asli (JAKOA) www.jakoa.
gov.my (Accessed on 6 August 2021)
20. Kementerian Pendidikan Malaysia (2017), Pengoperasian Educational Research Ap-
plication System Versi 2.0 (ERAS 2.0) Bagi Permohonan Menjalankan Penyelidikan di
Sekolah, KV, KM, IPG, PPD, JPN dan Bahagian di bawah KPM www.eras.moe.gov.my
(Accessed on 27 September 2021)
21. Economic Planning Unit, Prime Minister’s Department (1999), Regulations for Con-
ducting Research in Malaysia (EPU): General Circular Bil 3/1999, 31 July 1999. Avail-
able at: https://www.epu.gov.my/en/resources/guidelines-and-procedures/undertak-
ing-research-malaysia (Accessed on 6 August 2021).
22. Economic Planning Unit, Prime Minister’s Department (2011), Regulations For Con-
ducting Research in Malaysia (EPU) General Circular Bil 2/2011: Amendment of Gen-
eral Circular Bil 3/1999, 14 February 2011. Available at: https://www.epu.gov.my/en/
resources/guidelines-and-procedures/undertaking-research-malaysia (Accessed on 6
August 2021).
23. National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. Ma-
laysian Guidelines for The Conduct of Bioavailability and Bioequivalence Studies 2000:
04 September 2000 (Accessed on 6 August 2021).
24. National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia
(2004). ASEAN Guidelines for The Conduct of Bioavailability and Bioequivalence Stud-
ies, 21 July 2004. Available at https://www.npra.gov.my/images/ .(Accessed on 20
August 2021).
25. Guidelines_Central/Guidelines_on_Bioequivalence_BE/ASEAN_BE_Guide-
lines-amended_according_to1st_BABE_TWG15th_PPWG.pdf`. Accessed on 25
Augst 2021)
26. Bansal, S., Mahendiratta, S., Kumar, S., Sarma, P., Prakash, A., & Medhi, B. (2019).
Collaborative research in the modern era: Need and challenges. Indian journal of phar-
macology, 51(3), 137–139. https://doi.org/10.4103/ijp.IJP_394_19 . (Accessed on 13
August 2021)
27. https://www.uaf.edu/mou-moa/step-by-step-process/ (Accessed on 26 July 2021)
28. International Committee of Medical Journal Editors. Available at: http://www.icmje.org
(Accessed on 26 July 2021).
29. National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia
(2020). Malaysian Guideline for Application of Clinical Trial Import Licence and Clinical
Trial Exemption, 7th Edition, August 2020.
30. Pharmaceutical Services Programme, Ministry of Health Malaysia. Control Drug and
Cosmetic Regulation 1984.
31. Medical Practice Division, Ministry of Health Malaysia. Private Healthcare Facilities &
Services Act 1998.
32. Medical Device Authority, Ministry of Health Malaysia. Medical Device (Exemption)
Order 2016.
33. Diseases Control Division, Ministry of Health Malaysia. Garispanduan Pengimportan
dan Pengeksportan Tisu Manusia Atau Mana-Mana Bahagiannya, Edisi Pertama, 2006.
Available at <https://www.moh.gov.my/moh/images/gallery/Garispanduan/PubHea/
GP_Tisu.pdf>

34 NIH Guidelines for Conducting Research in MOH, 2021